🇺🇸 FDA

Drug profile · INN

aspirin

PROPOXYPHENE COMPOUND 65

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

aspirin (PROPOXYPHENE COMPOUND 65) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN aspirin
Brand PROPOXYPHENE COMPOUND 65
Route ORAL
Formulation CAPSULE
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 12298319

    Method for measuring alpha value of muscarinic M1 receptor positive allosteric modulators

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12129476

    Methods for measuring the potency of AADC viral vectors

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10184931

    Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10018638

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9779497

    Measuring glomerular number from kidney MRI images

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9689042

    Use of glycolytic pathways for inhibiting or measuring oncogenic signaling

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9410913

    Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

    Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9360446

    Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

    Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is aspirin?

aspirin (PROPOXYPHENE COMPOUND 65) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for aspirin?

PROPOXYPHENE COMPOUND 65 is a marketed brand name for aspirin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of aspirin?

aspirin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.